Device Trial Radar · NCT04365374
Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile-ROADS (Radiation One and Done Study)
Last checked: Nov 20, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
230
Planned (sponsor's estimate)
Start
Apr 6, 2021
Primary completion
Aug 30, 2029
Study completion Aug 30, 2029
Sponsor
- Lead sponsor
- GT Medical Technologies, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Apr 28, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This trial will be a randomized controlled study comparing the efficacy and safety of intraoperative radiation therapy using GammaTilesTM (GT) versus SRT 3-4 weeks following metastatic tumor resection which is the current standard of care.
Conditions
- Brain Metastases
Interventions
Gamma Tile-Surgically Targeted Radiation Therapy (STaRT)Device
GammaTiles are a permanently implanted radiation device consisting of Cs-131 seeds positioned within a collagen tile
Stereotactic Radiation TherapyRadiation
External Beam Radiation Therapy
Primary outcomes
What the sponsor says the trial is designed to measure.
- Surgical bed recurrence-free survival (SB-RFS) from the time of randomization up to 2 years post radiation.Time frame: up to 2 years post-radiation
Locations
37 sites in 1 country. Site status is shown where the registry gives one.
HonorHeath Scottsdale Osborn Medical Center
Phoenix, Arizona
University of Arkansas Medical Center
Little Rock, Arkansas
Ascension St. Vincent's- Riverside
Jacksonville, Florida
34 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.